BioLight Life Sciences Second Quarter 2023 Earnings: ₪3.72 loss per share (vs ₪0.40 profit in 2Q 2022)

BioLight Life Sciences (TLV:BOLT) Second Quarter 2023 Results

Key Financial Results

• Net loss: ₪17.3m (down from ₪1.84m profit in 2Q 2022).
• ₪3.72 loss per share (down from ₪0.40 profit in 2Q 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

BioLight Life Sciences shares are down 6.8% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 5 warning signs for BioLight Life Sciences that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.